Sitagliptin - Cas 486460-32-6, C16h15f6n5o Molecular Formula, Antihyperglycemic Dpp-4 Inhibitor For Diabetes Management

We are engaged in offering excellent quality Sitagliptin to our valuable clients.
CAS: 486460-32-6
Molecular formula: C16H15F6N5O
Molecular weight: 407.32

Sitagliptin (INN; previously identified as MK-0431 and marketed as the phosphate salt under the trade name Januvia) is an oral antihyperglycemic (antidiabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class. It was developed, and is marketed, by Merck & Co. This enzyme-inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents (such as metformin or a thiazolidinedione) for treatment of diabetes mellitus type 2. The benefit of this medicine is its fewer side effects (e.g., less hypoglycemia, less weight gain) in the control of blood glucose values. While safety is its advantage, efficacy is often challenged as it is often recommended to be combined with other agents like metformin. Clients can avail this Sitagliptin at industry leading prices from us.